# Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries:

> **NCT01912937** · PHASE2,PHASE3 · COMPLETED · sponsor: **Spectranetics Corporation** · enrollment: 25 (actual)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DEVICE:** Angioplasty treatment with the CVI Drug-coated Balloon (DCB)

## Key facts

- **NCT ID:** NCT01912937
- **Lead sponsor:** Spectranetics Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2016-06
- **Final completion:** 2017-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01912937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01912937, "Pharmacokinetic Study of Drug-coated Angioplasty Balloons in the Superficial Femoral or Popliteal Arteries:". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01912937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*